Have a personal or library account? Click to login
A multidisciplinary approach to optimising the virtual management of haemophilia: a roundtable meeting of UK experts Cover

A multidisciplinary approach to optimising the virtual management of haemophilia: a roundtable meeting of UK experts

Open Access
|Dec 2023

References

  1. Centers for Disease Control and Prevention. What is Hemophilia? 2022. Available from https://www.cdc.gov/ncbddd/hemophilia/facts.html (accessed January 2023).
  2. Beny K, du Sartz de Vigneulles B, Carrouel F, et al. Haemophilia in France: Modelisation of the clinical pathway for patients. Int J Environ Res Public Health 2022; 19(2): 646. doi: 10.3390/ijerph19020646.
  3. Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia 2020; 26 Suppl 6: 1-158. doi: 10.1111/hae.14046.
  4. Mehta P, Reddivari AKR. Hemophilia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 30 Sep 2022.
  5. Roche. Summary of Product Characteristics – Hemlibra. Available from https://www.ema.europa.eu/en/documents/product-information/hemlibra-epar-product-information_en.pdf (accessed March 2023).
  6. Genentech. Prescribing Information – HEMLIBRA. Available from https://www.gene.com/download/pdf/hemlibra_prescribing.pdf (accessed March 2023).
  7. Leebeek FWG, Miesbach W. Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues. Blood 2021; 138(11): 923-931. doi: 10.1182/blood.2019003777.
  8. BioMarin. Summary of Product Characteristics – ROCTAVIAN. Available from https://www.ema.europa.eu/en/documents/product-information/roctavian-epar-product-information_en.pdf (accessed March 2023).
  9. BioMarin. Prescribing Information – ROCTAVIAN. Available from https://d34r3hkxgxjdtw.cloudfront.net/6f836309-d95f-42af-b717-2efa058ad82d/78bf2bcb-7068-4774-b962-a35c53704fc1/78bf2bcb-7068-4774-b962-a35c53704fc1_source__v.pdf (accessed July 2023).
  10. CSL Behring. Prescribing Information – HEMGENIX. Available from https://labeling.cslbehring.com/PI/US/Hemgenix/EN/Hemgenix-Prescribing-Information.pdf (accessed January 2023).
  11. CSL Behring. Summary of Product Characteristics - Hemgenix. Available from https://www.ema.europa.eu/en/documents/product-information/hemgenix-epar-product-information_en.pdf (accessed March 2023).
  12. Medicines and Healthcare products Regulatory Agency. Orphan Registered Medicinal Products: HEMGENIX. 2023. Available from https://www.gov.uk/government/publications/orphan-registered-medicinal-products/orphan-register#hemgenix-1-x-1013-genome-copiesml-concentrate-for-solution-for-infusion (accessed July 2023).
  13. Hermans C, Noone D, Benson G, et al. Hemophilia treatment in 2021: Choosing the “optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians. Blood Rev 2021; 52: 100890. doi: 10.1016/j.blre.2021.100890.
  14. Krumb E, Hermans C. Living with a “hemophilia-free mind” – The new ambition of hemophilia care? Res Pract Thromb Haemost 2021; 5(5): e12567. doi: 10.1002/rth2.12567.
  15. O’Donovan M, Buckley C, Benson J, et al. Telehealth for delivery of haemophilia comprehensive care during the COVID-19 pandemic. Haemophilia 2020; 26(6): 984-990. doi: 10.1111/hae.14156.
  16. McKinsey & Company. Telehealth: A quarter-trillion-dollar post-COVID-19 reality? 9 July 2021. Available from https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/telehealth-a-quarter-trillion-dollar-post-covid-19-reality (accessed July 2023).
  17. de Kleijn P, Duport G, Jansone K, et al. European principles of care for physiotherapy provision for persons with inherited bleeding disorders: Perspectives of physiotherapists and patients. Haemophilia 2022; 28(4): 649-655. doi: 10.1111/hae.14566.
  18. Timmer MA, Blokzijl J, Schutgens REG, Veenhof C, Pisters MF. Coordinating physiotherapy care for persons with haemophilia. Haemophilia 2021; 27(6): 1051-1061. doi: 10.1111/hae.14404.
  19. Mulder K, McCabe E, Strike K, Nilson J. Developing clinical practice guidelines for physiotherapists working with people with inherited bleeding disorders. Haemophilia 2021; 27(4): 674-682. doi: 10.1111/hae.14327.
  20. Lee D, Le AO, Meganck M, Chamberland S, Pai A. Adding a clinical hemophilia pharmacist to the hemophilia comprehensive care model improves health care-related outcomes and drug-related costs in an integrated health care system. Perm J 2022; 26(3): 90-93. doi: 10.7812/TPP/21.192.
  21. St-Louis J, Chowdary P, Dolan G, et al. Multidisciplinary team care of patients with hemophilic arthropathy: A qualitative assessment of contemporary practice in the UK and Canada : Canada/UK: MDT Practices for Hemophilia. Clin Appl Thromb Hemost 2022; 28: 10760296211070002. doi: 10.1177/10760296211070002.
  22. Valentino LA, Baker JR, Butler R, et al. Integrated hemophilia patient care via a national network of care centers in the United States: a model for rare coagulation disorders. J Blood Med 2021; 12: 897-911. doi: 10.2147/JBM.S325031.
  23. Cortesi PA, Rocino A, Preti D, et al. Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view. Haemophilia 2022; 28(2): 254-263. doi: 10.1111/hae.14504.
  24. Gualtierotti R, Tafuri F, Arcudi S, et al. Current and emerging approaches for pain management in hemophilic arthropathy. Pain Ther 2022; 11: 1-15. doi: 10.1007/s40122-021-00345-x.
  25. Ghosh K, Ghosh K. Overcoming the challenges of treating hemophilia in resource-limited nations: a focus on medication access and adherence. Expert Rev Hematol 2021; 14(8): 721-730. doi: 10.1080/17474086.2021.1957826.
  26. Mbanya DN, Diop S, Ndoumba Mintya AN, El Kiaby M. Hemophilia care in Africa: Status and challenges. Transfus Clin Biol 2021; 28(2): 158-162. doi: 10.1016/j.tracli.2021.01.008.
  27. Kulkarni R. Use of telehealth in the delivery of comprehensive care for patients with haemophilia and other inherited bleeding disorders. Haemophilia 2018; 24(1): 33-42. doi: 10.1111/hae.13364.
  28. Qian W, Lam TT, Lam HHW, Li CK, Cheung YT. Telehealth interventions for improving self-management in patients with hemophilia: Scoping review of clinical studies. J Med Internet Res 2019; 21(7): e12340. doi: 10.2196/12340.
  29. Jacobson K, Hooke MC. Telehealth videoconferencing for children with hemophilia and their families: a clinical project. J Pediatr Oncol Nurs 2016; 33(4): 282-288. doi: 10.1177/1043454215607340.
  30. Alvarez-Roman MT, Kurnik K, PedNet Study G. Care for children with haemophilia during COVID-19: Data of the PedNet study group. Haemophilia 2021; 27(4): e537-e539. doi: 10.1111/hae.14286.
  31. Windyga J, Boban A, Zupan I, O’Connell N, Hermans C. Changing paradigms of hemophilia care across larger specialized treatment centers in the European region. Ther Adv Hematol 2022; 13: 20406207221088462. doi: 10.1177/20406207221088462.
  32. Olusanya OA, Ammar N, Brakefield WS, et al. HemPHL: A personal health library and mHealth recommender to promote self-management of hemophilia. Stud Health Technol Inform 2021; 281: 550-554. doi: 10.3233/SHTI210231.
  33. Dirzu N, Hotea I, Jitaru C, et al. Mobile health technology for the personalized therapy of hemophilia. Front Med (Lausanne) 2021; 8: 711973. doi: 10.3389/fmed.2021.711973.
  34. Sayers F, Manson H, Brennan B, et al. Virtual consultations: Providing alternative ways of supporting patients with inherited bleeding disorders. Haemophilia 2021; 27(4): e498-e501. doi: 10.1111/hae.14210.
  35. Aliaga-Castillo V, Horment-Lara G, Contreras-Sepúlveda F, Cruz-Montecinos C. Safety and effectiveness of telerehabilitation program in people with severe haemophilia in Chile. A qualitative study. Musculoskelet Sci Pract 2022; 60: 102565. doi: 10.1016/j.msksp.2022.102565.
  36. Flannery T, Bladen M, Hopper D, et al. Physiotherapy after COVID-19-”Zoom or room”. Haemophilia 2021; 27(4): e476-e478. doi: 10.1111/hae.14166.
  37. Lobet S, Timmer M, Königs C, et al. The role of physiotherapy in the new treatment landscape for haemophilia. J Clin Med 2021; 10(13): 2822. doi: 10.3390/jcm10132822.
  38. Banchev A, Goldmann G, Marquardt N, et al. Impact of telemedicine tools on record keeping and compliance in haemophilia care. Hamostaseologie 2019; 39(4): 347-354. doi: 10.1055/s-0038-1676128.
  39. Hay CRM, Xiang H, Scott M, et al. The Haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation. Haemophilia 2017; 23(5): 728-735. doi: 10.1111/hae.13287.
  40. Tiede A, Bonanad S, Santamaria A, et al. Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diary. Haemophilia 2020; 26(6): 999-1008. doi: 10.1111/hae.14178.
  41. Cheung YT, Lam PH, Lam TT, Lam HHW, Li CK. Technology acceptance among patients with hemophilia in Hong Kong and their expectations of a mobile health app to promote self-management: Survey study. JMIR Form Res 2021; 5(9): e27985. doi: 10.2196/27985.
  42. Bhatt N, Boggio L, Simpson ML. Using an educational intervention to assess and improve disease-specific knowledge and health literacy and numeracy in adolescents and young adults with haemophilia A and B. Haemophilia 2021; 27(2): 229-236. doi: 10.1111/hae.14228.
  43. Zapata AC, Araya AX. Educational needs of parents of hemophiliac children: An approach to comprehensive care. Andes Pediatr 2021; 92(2): 219-225. doi: 10.32641/andespediatr.v92i2.1090.
  44. Sun J, Zhou X, Hu N. Factor VIII replacement prophylaxis in patients with hemophilia A transitioning to adults: a systematic literature review. Orphanet J Rare Dis 2021; 16(1): 287. doi: 10.1186/s13023-021-01919-w.
  45. Mancuso ME, Male C, Kenet G, et al. Prophylaxis in children with haemophilia in an evolving treatment landscape. Haemophilia 2021; 27(6): 889-896. doi: 10.1111/hae.14412
  46. Li CL, Strike K, Matino D, Bhatt M, Decker K, Chan AK. Telemedicine in hemophilia: A comprehensive review. Res Pract Thromb Haemost 2021; 5(S2): 451-452 (PB0597). Available from https://abstracts.isth.org/abstract/telemedicine-in-hemophilia-a-comprehensive-review/.
Language: English
Page range: 138 - 154
Published on: Dec 29, 2023
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2023 Gary Benson, Trupti Bhandari, Keith Gomez, Kerry-Ann Holder, David Stephensen, Alice Wilkinson, Sarah Mangles, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.